Drug Trial Radar · NCT04811092
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)
Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
321
Actual
Start
Mar 18, 2022
Primary completion
Apr 3, 2025
Study completion Apr 3, 2025
Sponsor
- Lead sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USAIndustry
- Sponsor type
- Industry
- First posted
- Mar 23, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the effects of sotatercept (MK-7962, formerly called ACE-011) treatment (plus background pulmonary arterial hypertension \[PAH\] therapy) versus placebo (plus background PAH therapy) on time to clinical worsening (TTCW) in participants who are newly diagnosed with PAH and are at intermediate or high-risk of disease progression.
Conditions
- Pulmonary Arterial Hypertension
Interventions
SotaterceptDrug
SC injection
PlaceboOther
Placebo-matched SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Time to Clinical WorseningTime frame: Up to ~35 months
Locations
152 sites in 27 countries. Site status is shown where the registry gives one.
Arizona Pulmonary Specialists ( Site 1010)
Scottsdale, Arizona
University of Arizona ( Site 1006)
Tucson, Arizona
University of California San Diego ( Site 1002)
La Jolla, California
UCLA Medical Center ( Site 1068)
Los Angeles, California
University of California Irvine ( Site 1086)
Orange, California
Santa Barbara Pulmonary Associates ( Site 1060)
Santa Barbara, California
University of California Davis Medical Center ( Site 1064)
Sherman Oaks, California
University of Colorado Hospital ( Site 1013)
Aurora, Colorado
AdventHealth Medical Group Advanced Lung Disease ( Site 1058)
Orlando, Florida
University of Iowa Hospital and Clinics ( Site 1050)
Iowa City, Iowa
Johns Hopkins Hospital ( Site 1036)
Baltimore, Maryland
Tufts Medical Center - PPDS ( Site 1014)
Boston, Massachusetts
Boston Medical Center ( Site 1012)
Boston, Massachusetts
University of Michigan ( Site 1011)
Ann Arbor, Michigan
University of Kansas Medical Center ( Site 1020)
Kansas City, Missouri
Washington University School of Medicine ( Site 1022)
St Louis, Missouri
University of New Mexico, Health Sciences Center ( Site 1048)
Albuquerque, New Mexico
NYU Langone Health ( Site 1052)
New York, New York
University of North Carolina at Chapel Hill ( Site 1042)
Chapel Hill, North Carolina
The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital ( Site 1001)
Cincinnati, Ohio
University of Cincinnati ( Site 1035)
Cincinnati, Ohio
The Cleveland Clinic Foundation Taussig Cancer Center ( Site 1065)
Cleveland, Ohio
Nazih Zuhdi Transplantation Institute ( Site 1084)
Oklahoma City, Oklahoma
Oregon Health & Science University ( Site 1054)
Portland, Oregon
Medical University of South Carolina ( Site 1003)
Charleston, South Carolina
Vanderbilt University Medical Center ( Site 1027)
Nashville, Tennessee
University of Texas Southwestern Medical Center ( Site 1038)
Dallas, Texas
University of Utah ( Site 1049)
Salt Lake City, Utah
Sanatorio Allende ( Site 1908)
Córdoba, Argentina
Hospital Provincial Dr. Jose M. Cullen ( Site 1902)
Santa Fe, Argentina
Cardiologia Palermo ( Site 1911)
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Centro Medico Dra De Salvo ( Site 1904)
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Hospital Universitario Austral ( Site 1901)
Pilar, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Quilmes ( Site 1903)
Quilmes, Buenos Aires, Argentina
Instituto De Enfermedades Respiratorias E Investigacion Medica ( Site 1910)
Villa Vatteone, Buenos Aires, Argentina
Instituto Médico DAMIC ( Site 1909)
Córdoba, Córdoba Province, Argentina
Instituto Medico Rio Cuarto ( Site 1907)
Río Cuarto, Córdoba Province, Argentina
Hospital Provincial del Centenario ( Site 1912)
Rosario, Santa Fe Province, Argentina
Instituto Cardiovascular de Rosario ( Site 1906)
Rosario, Santa Fe Province, Argentina
Sanatorio Parque ( Site 1905)
Rosario, Santa Fe Province, Argentina
Showing 40 of 152 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.